Renaissance Technologies’s Guardion Health Sciences, Inc. Common Stock GHSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-38,804
| Closed | -$215K | – | 4015 |
|
|
2024
Q3 | $215K | Buy |
38,804
+1,884
| +5% | +$19.1K | ﹤0.01% | 3103 |
|
|
2024
Q2 | $370K | Sell |
36,920
-900
| -2% | -$7.99K | ﹤0.01% | 2823 |
|
|
2024
Q1 | $341K | Sell |
37,820
-200
| -0.5% | -$1.48K | ﹤0.01% | 3034 |
|
|
2023
Q4 | $203K | Sell |
38,020
-1,700
| -4% | -$10.3K | ﹤0.01% | 3125 |
|
|
2023
Q3 | $293K | Buy |
39,720
+2,100
| +6% | +$16.2K | ﹤0.01% | 2939 |
|
|
2023
Q2 | $293K | Buy |
37,620
+2,200
| +6% | +$13.8K | ﹤0.01% | 3135 |
|
|
2023
Q1 | $216K | Buy |
35,420
+2,005
| +6% | +$13.3K | ﹤0.01% | 3248 |
|
|
2022
Q4 | $242K | Sell |
33,415
-1,064
| -3% | -$8.52K | ﹤0.01% | 3330 |
|
|
2022
Q3 | $238K | Buy |
34,479
+2,984
| +9% | +$22.7K | ﹤0.01% | 3306 |
|
|
2022
Q2 | $228K | Sell |
31,495
-13,030
| -29% | -$114K | ﹤0.01% | 3592 |
|
|
2022
Q1 | $516K | Buy |
44,525
+39,551
| +795% | +$803K | ﹤0.01% | 3170 |
|
|
2021
Q4 | $161K | Sell |
4,974
-6,722
| -57% | -$361K | ﹤0.01% | 3588 |
|
|
2021
Q3 | $743K | Buy |
11,696
+4,750
| +68% | +$316K | ﹤0.01% | 2708 |
|
|
2021
Q2 | $611K | Buy |
6,946
+1,396
| +25% | +$121K | ﹤0.01% | 2884 |
|
|
2021
Q1 | $666K | Buy |
+5,550
| New | +$1.12M | ﹤0.01% | 2795 |
|
|
2020
Q4 | – | Sell |
-410
| Closed | -$25K | – | 3792 |
|
|
2020
Q3 | $25K | Buy |
+410
| New | +$42.5K | ﹤0.01% | 3313 |
|
Renaissance Technologies's GHSI Position: Q4 2024 in Review
Renaissance Technologies sold out of Guardion Health Sciences, Inc. Common Stock (GHSI) in Q4 2024, closing a stake of 38,804 shares — an estimated $215K sold.
Renaissance Technologies first reported a position in GHSI in Q3 2020 and held it in 16 quarters. The position peaked at $743K in Q3 2021. 0 funds tracked by Wall St. Rank hold GHSI as of Q4 2024.
- Renaissance Technologies reported no remaining Guardion Health Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Renaissance Technologies sold 38,804 Guardion Health Sciences, Inc. Common Stock shares in Q4 2024, an estimated $215K.
- Renaissance Technologies first reported a position in Guardion Health Sciences, Inc. Common Stock in Q3 2020 and held it in 16 quarters.
- Renaissance Technologies's Guardion Health Sciences, Inc. Common Stock position peaked at $743K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Guardion Health Sciences, Inc. Common Stock as of Q4 2024.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.